Background: Decontamination of gutta percha cones was important factor for success of root canal treatment. The aim of the present in vitro study was to identify and to compare the antimicrobial effect of following disinfection solutions: 0.2 ...
Nagham A Al-Hyali
doaj
Evaluation of clinical and radiographic success of sodium hypochlorite and formocresol pulpotomy in primary teeth [PDF]
Bu çalışmada süt dişi amputasyon tedavilerinde %5'lik sodyum hipoklorit ve amputasyon tedavilerinde "altın standart" kabul edilen formokrezolün başarısının klinik ve radyografik olarak değerlendirilmesi amaçlanmıştır.
Öztoprak, Ece
core
Clinical and Radiographic Evaluation of Nigella sativa and Aloe vera as Pulpotomy Medicaments in Primary Teeth: A Randomized Controlled Trial. [PDF]
Sharaf RM +3 more
europepmc +1 more source
Success Rate of Formocresol Pulpotomy versus Mineral Trioxide Aggregate in Human Primary Molar Tooth
Background: In spite of long time and broad use of formaldehyde derivates (Fixation agent) in primary tooth pulp treatment, There is some concerns about these derivates such as variability, inconsistency success rate, mutagenicity, cytotoxicity ...
S E Jabbarifar, A A Khademi, D Ghasemi
doaj
Comparative Evaluation of Chlorhexidine Polymer Scaffold, 3Mixtatin, and Formocresol for Vital Primary Pulp Therapy: A Randomized 6-month Clinical Study. [PDF]
Goel N +5 more
europepmc +1 more source
Long-term Outcomes of Invasive Pulp Therapies in Primary Teeth: A Systematic Review and Meta-analysis. [PDF]
Vaiude A, Jawdekar A, Mistry LN.
europepmc +1 more source
Histological investigation of the effects of chitosan and 3 different pulpotomy agents on rat dental pulps. [PDF]
Pedük K +5 more
europepmc +1 more source
A histopathological comparison of formocresol, propolis, and growth factor as pulpotomy medicaments in primary teeth: An in vivo study. [PDF]
Goinka C +5 more
europepmc +1 more source
Evaluation of Chitosan (Axiostat®) as a Pulpotomy Agent in Primary Molars: An <i>In Vivo</i> Study. [PDF]
Krishna N, Rai K, Manju R, Lolayekar N.
europepmc +1 more source

